Search Within

Omar Ibrahim Abdel-Wahab

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (127)
  2. Meeting Abstract (81)
  3. Book Section (1)
Groups
  1. Center for Hematologic Malignancies (209)
  2. Department of Medicine (209)
  3. Executive Committee, Center for Hematologic Malignancies (209)
  4. GSK Faculty (209)
  5. Hematologic Malignancies, Division of (209)
  6. Human Oncology and Pathogenesis Program (209)

More Groups

People
  1. Ross Levine (166)
  2. Martin Tallman (51)
  3. Jay Patel (40)
  4. Raajit Rampal (28)
  5. Young Rock Chung (24)
  6. Michael Berger (19)

More People

Years
  1. 2025 (3)
  2. 2024 (1)
  3. 2023 (10)
  4. 2022 (11)
  5. 2021 (3)
  6. 2020 (8)

More Years

Publications
  1. Blood (75)
  2. Leukemia (15)
  3. Cancer Cell (12)
  4. Cancer Research (12)
  5. Haematologica (8)
  6. Nature (6)

More Publications

Publishers
  1. American Society of Hematology (80)
  2. Nature Publishing Group (39)
  3. American Association for Cancer Research (20)
  4. Cell Press (16)
  5. Ferrata Storti Foundation (8)
  6. Elsevier Ltd (5)

More Publishers

Results (209)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The potential for isocitrate dehydrogenase mutations to produce 2-hydroxyglutarate depends on allele specificity and subcellular compartmentalization
    Journal Article

    Ward, P. S.; Lu, C.; Cross, J. R.; Abdel-Wahab, O.; Levine, R. L.; Schwartz, G. K.; Thompson, C. B.
    Journal of Biological Chemistry (2013)

    Fulltext@MSK | Save
  • 2-Hydroxyglutarate in IDH mutant acute myeloid leukemia: Predicting patient responses, minimal residual disease and correlations with methylcytosine and hydroxymethylcytosine levels
    Journal Article

    Pollyea, D. A.; Kohrt, H. E.; Zhang, B.; Zehnder, J.; Schenkein, D.; Fantin, V.; Straley, K.; Vasanthakumar, A.; Abdel-Wahab, O.; Levine, R.; more...
    Leukemia and Lymphoma (2013)

    Fulltext@MSK | Save
  • Acute myeloid leukemia with translocation t(8;16) presents with features which mimic acute promyelocytic leukemia and is associated with poor prognosis
    Journal Article

    Diab, A.; Zickl, L.; Abdel-Wahab, O.; Jhanwar, S.; Gulam, M. A.; Panageas, K. S.; Patel, J. P.; Jurcic, J.; Maslak, P.; Paietta, E.; more...
    Leukemia Research (2013)

    Fulltext@MSK | Save
  • Prospective evaluation of serial 2-hydroxyglutarate in acute myeloid leukemia (AML) to determine response to therapy and predict relapse
    Meeting Abstract

    Fathi, A. T.; Abdel-Wahab, O. I.; Sadrzadeh, H.; Foster, J.; Burke, M.; Borger, D. R.; Iafrate, A. J.; Adamia, S.; Liu, S.; Ballen, K. K.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Development of a murine model for leukemic transformation of myeloproliferative neoplasms for preclinical therapeutic studies
    Meeting Abstract

    Rampal, R. K.; Pandey, S.; Abdel-Wahab, O.; Tsai, J. J.; Manshouri, T.; Park, C. Y.; Verstovsek, S.; Levine, R. L.
    Blood (2012)

    Fulltext@MSK | Save
  • Removal of macrophages from the erythroid niche impairs stress erythropoiesis but improves pathophysiology of polycythemia vera and beta-thalassemia
    Meeting Abstract

    Ramos, P.; Casu, C.; Gardenghi, S.; Breda, L.; Crielaard, B. J.; Gupta, R.; Guy, E.; Mariongiu, M. F.; Levine, R. L.; Abdel-Wahab, O.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • Serum 2-hydroxyglutarate levels predict isocitrate dehydrogenase mutations and clinical outcome in acute myeloid leukemia
    Meeting Abstract

    DiNardo, C. D.; Levine, R. L.; Propert, K. J.; Loren, A. W.; Paietta, E.; Sun, Z. X.; Straley, K.; Yen, K.; Patel, J. P.; Agresta, S.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • Conditional deletion of asxl1 results in myelodysplasia
    Meeting Abstract

    Abdel-Wahab, O.; Gao, J.; Adli, M.; Chung, Y. R.; Koche, R.; Shih, A. H.; Pandey, S.; LaFave, L. M.; Ndiaye-Lobry, D.; Shin, Y. S.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • Progression of RAS-mutant leukemia during RAF inhibitor treatment
    Journal Article

    Callahan, M. K.; Rampal, R.; Harding, J. J.; Klimek, V. M.; Chung, Y. R.; Merghoub, T.; Wolchok, J. D.; Solit, D. B.; Rosen, N.; Abdel-Wahab, O.; more...
    New England Journal of Medicine (2012)

    Fulltext@MSK | Save
  • Tumor suppressor screens of 3p chromatin modulators link BAP1 mutations to poor clinical outcomes in clear cell renal cell carcinoma
    Meeting Abstract

    Hakimi, A. A.; Chen, Y. B.; Wren, J.; Ostrovnaya, I.; Gonen, M.; Abdel-Wahab, O.; Heguy, A.; Liu, H.; Takeda, S.; Tickoo, S. K.; more...
    BJU International (2012)

    Fulltext@MSK | Save